Clinical trial

NATriuretic Response to Expansion and dIUretics in huMans With Heart Failure

NCT04235062

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2020-04-01

PhaseNA

Study timeline

Study start (actual)2020-04-01Date precision: day

Registry last updated2022-04-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Heart Failureunresolved

Interventions

Ringer's (8.6 g/L sodium chloride, 0.33 g/L calcium chloride, 0.3 g/L potassium chloride) SolutionDRUG

Intravenous Bolus FurosemideDRUG

Sponsors & collaborators

Momentum Research, Inc.lead sponsor

Saint-Louis-Lariboisière University Hospitalscollaborator

Abbottcollaborator

Mapped research locations

MoscowRussia4 Saint PetersburgRussia1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04235062 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.